Barrington Research Maintains Outperform on US Physical Therapy, Raises Price Target to $110
Benzinga Newsdesk 1 hour ago
Analyst RatingsNewsPrice Target
Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:USPH) with a Outperform and raises the price target from $98 to $110.
Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:USPH) with a Outperform and raises the price target from $98 to $110.